Alvarez, Ricardo H <br/><br/>
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.  [electronic resource] 

 -  Cancer  Mar 2010 
 - 1210-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.24901  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Combined Modality Therapy<br/>Cyclophosphamide<br/>Disease-Free Survival<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil<br/>Humans<br/>Methotrexate<br/>Middle Aged<br/>Radiotherapy, Adjuvant<br/>Taxoids--administration & dosage